Dogwood Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Dogwood Therapeutics, Inc. (DWTX) reported Earnings Per Share, Basic and Diluted of -$0.49 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-12
- Dogwood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.49.
- Dogwood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.51.
- Dogwood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.37.
- Dogwood Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.56.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month |
|---|---|---|---|
| 2021-09-30 | -$0.49 10-Q · filed 2021-11-12 | -$1.37 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$0.51 10-Q · filed 2021-08-13 | -$0.88 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$0.37 10-Q · filed 2021-05-14 | ||
| 2020-09-30 | -$0.56 10-Q · filed 2021-11-12 | -$0.80 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$0.14 10-Q · filed 2021-08-13 | -$0.23 10-Q · filed 2021-08-13 | |
| 2020-03-31 | -$0.10 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |